General AML

1st NCRI AML academy meeting | What is the optimum treatment strategy for high-risk myelodysplastic syndrome?

L: English

During the 1st NCRI AML academy meeting, the AML Global Portal was pleased to speak to Professor David Bowen from Leeds Teaching Hospitals, Leeds, UK about treatment strategies for high-risk myelodysplastic syndrome.

Was this article informative? Thank you for your feedback!